Literature DB >> 22118297

Association of the ANTXR2 gene polymorphism and ankylosing spondylitis in Chinese Han.

C Guo1, Y Xia, Q Yang, R Qiu, H Zhao, Q Liu.   

Abstract

OBJECTIVE: Ankylosing spondylitis (AS) is an inflammatory disease of unknown origin. Both genetic and environmental factors are involved. A recent genome-wide association study (GWAS) found anthrax toxin receptor 2 (ANTXR2) to be associated with AS in Caucasians. We aimed to investigate whether the ANTXR2 polymorphism is also associated with AS in a Chinese Shandong Han population.
METHODS: From 2008 to 2009, we recruited 309 patients with AS and 384 age- and sex-matched controls of Han nationality. We selected six single nucleotide polymorphisms (SNPs) of ANTXR2 (rs4333130, rs6534708, rs6818557, rs12646132, rs12509658, and rs13140055) and genotyped them by polymerase chain reaction restriction fragment-length polymorphism (PCR-RFLP) and Taqman methods. We analysed linkage disequilibrium and constructed haplotypes.
RESULTS: Cases and controls did not differ in the frequency of ANTXR2 alleles, genotypes, or haplotypes. Thus, the six SNPs of ANTXR2 are not associated with AS in our Chinese Shandong Han population.
CONCLUSIONS: ANTXR2 might not be a susceptibility gene of AS in Chinese Han.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22118297     DOI: 10.3109/03009742.2011.600700

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

1.  Anthrax toxin receptor 2 gene (ANTXR2) rs4333130 is associated with ankylosing spondylitis.

Authors:  Yanjuan Ou
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  Ankylosis in ankylosing spondylitis: current concepts.

Authors:  Nigil Haroon
Journal:  Clin Rheumatol       Date:  2015-06       Impact factor: 2.980

3.  A complex role of anthrax toxin receptor 2 polymorphisms and capillary morphogenesis protein 2 in ankylosing spondylitis pathogenesis.

Authors:  Zhijian Zhang; Kun Yu; Dongfa Dai; Fang Yuan; Fei Liang; Nan Liu; Yongzhi Xi; Yu-Ying Sun
Journal:  Clin Rheumatol       Date:  2016-01-04       Impact factor: 2.980

4.  Association Between Dentin Matrix Protein 1 (rs10019009) Polymorphism and Ankylosing Spondylitis in a Chinese Han Population from Shandong Province.

Authors:  Jian-Min Liu; Ya-Zhou Cui; Geng-Lin Zhang; Xiao-Yan Zhou; Jing-Xiang Pang; Xue-Zheng Wang; Jin-Xiang Han
Journal:  Chin Med J (Engl)       Date:  2016-03-20       Impact factor: 2.628

5.  Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis.

Authors:  Ruxandra Schiotis; Nerea Bartolomé; Alejandra Sánchez; Magdalena Szczypiorska; Jesús Sanz; Eduardo Cuende; Eduardo Collantes Estevez; Antonio Martínez; Diego Tejedor; Marta Artieda; Anca Buzoianu; Juan Mulero
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

6.  Ankylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2).

Authors:  T Karaderi; S M Keidel; J J Pointon; L H Appleton; M A Brown; D M Evans; B P Wordsworth
Journal:  Ann Rheum Dis       Date:  2014-08-28       Impact factor: 19.103

7.  Anthrax Susceptibility: Human Genetic Polymorphisms Modulating ANTXR2 Expression.

Authors:  Zhang Zhang; Yan Zhang; Minglei Shi; Bingyu Ye; Wenlong Shen; Ping Li; Lingyue Xing; Xiaopeng Zhang; Lihua Hou; Junjie Xu; Zhihu Zhao; Wei Chen
Journal:  Toxins (Basel)       Date:  2015-12-22       Impact factor: 4.546

8.  Protective effect of anthrax toxin receptor 2 polymorphism rs4333130 against the risk of ankylosing spondylitis.

Authors:  Haitao Xu; Yiming Qu
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

9.  Case-Control Study and Meta-Analysis Show a Weak Association between ANTXR2 Polymorphisms and Ankylosing Spondylitis in Chinese Han.

Authors:  Jiayue Hu; Liping Du; Wencheng Su; Shengyun Liu; Jing Deng; Qinfeng Cao; Gangxiang Yuan; Aize Kijlstra; Peizeng Yang
Journal:  Biomed Res Int       Date:  2018-09-05       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.